Preparation method of drug-loaded capsule with core-shell structure
A core-shell structure and drug-carrying technology, applied in the field of pesticides, can solve problems such as easy rupture of drug-carrying capsule shells
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0050]2.6g lambda-cyhalothrin technical substance (96%) is dissolved in 5g cyclohexanone as oil phase; With 0.2g polyvinyl alcohol, 0.5g calcium dodecylbenzenesulfonate, 2.4g sodium lignosulfonate Dissolve in deionized water to form the aqueous phase. Add the oil phase to the water phase under magnetic stirring at 400 rpm to form an oil-in-water emulsion; slowly add 2 g of octadecyldimethylbenzyl ammonium chloride to the above emulsion, and stir for 20 minutes; Then add 0.1g10% ferric chloride aqueous solution; stir for 20 minutes; then add 0.1g xanthan gum, 2g ethylene glycol, and deionized water to make up 100g; promptly make 2.5% lambda-cyhalothrin microcapsule suspension, the obtained Scanning electron microscope images of drug-loaded microcapsules image 3 as shown in image 3 As shown, in the microcapsule suspension obtained in the present invention, the microcapsules are all stable spheres, and no crystals of the original drug are seen to separate out, indicating that...
Embodiment 2
[0054] 5.26g Abamectin former drug (95%) is dissolved in 15g cyclohexanone as oil phase; With 0.3g polyvinyl alcohol, 0.8g sodium dodecylbenzenesulfonate, 2g calcium lignosulfonate is dissolved in An aqueous phase is formed in ionized water. Add the oil phase to the water phase under magnetic stirring at 400 rpm to form an oil-in-water emulsion; then add 2.5g of tetradecyldimethylbenzyl ammonium chloride and slowly add it to the above emulsion, and stir for 20 minutes; Then add 0.2g10% copper chloride aqueous solution; stir for 20 minutes; then add 0.1g xanthan gum, 2g ethylene glycol, and deionized water to make up 100g; promptly make 5% abamectin nanocapsule suspension.
[0055] After testing, the average particle diameter of the preparation is 254nm, the encapsulation rate is 94%, the suspension rate is >95%, and the low temperature stability and thermal storage stability are all qualified.
Embodiment 3
[0057] 1.41g emamectin benzoate former medicine (71%) is dissolved in 10g cyclohexanone as oil phase; With 0.3g polyvinyl alcohol, 0.8g sodium dodecylbenzenesulfonate, 2g lignin Calcium sulfonate was dissolved in deionized water to form an aqueous phase. Add the oil phase to the water phase under magnetic stirring at 400 rpm to form an oil-in-water emulsion; then add 2.5 g of dioctadecylmethylbenzyl ammonium chloride and slowly add it to the above emulsion, and stir for 20 minutes; Then add 0.2g10% ferric chloride aqueous solution; stir for 20 minutes; then add 0.1g xanthan gum, 2g ethylene glycol, and deionized water to make up 100g; promptly make 1% emamectin benzoate micro capsule suspension.
[0058] After testing, the average particle size of the preparation is 305nm, the encapsulation rate is 95%, the suspension rate is >98%, and the low temperature stability and thermal storage stability are all qualified.
PUM
Login to View More Abstract
Description
Claims
Application Information
Login to View More 


